A Global Active Surveillance for Community Acquired Pneumonia

NCT00929721 | Completed

• 1 other identifier: 6115A1-4000
• Study Type: interventional
• Target: 5,172
• Locations: 1 country
• Sites: 1

Brief Summary

This study is an observational surveillance study to identify adults 50 years and older who present to a study healthcare facility with signs and symptoms of Community-Acquired Pneumonia.

Conditions

Community Acquired Pneumonia

Keywords

CAP

Outcome Measures

Primary Outcomes (1)

• Incidence rates of CAP in adults 50 years and older

  up to 120 days from enrollment

Secondary Outcomes (1)

• Frequency of bacterial agents associated with CAP, Case fatality and incidence rates of CAP number and characteristics of subjects from outpatient clinics, emergency rooms, and hospital in-patient departments

  up to 120 days from enrollment

Study Arms (1)

Subjects with Community-Acquired Pneumonia

OTHER

Subjects with Community-Acquired Pneumonia

Procedure: Blood draw; Procedure: Chest X-ray; Procedure: urine specimen; Procedure: Nasopharyngeal swab; Procedure: sputum

Interventions

Blood draw PROCEDURE

culture for Streptococcus pneumoniae Frequency-1

Also known as: Blood stick

Subjects with Community-Acquired Pneumonia

Chest X-ray PROCEDURE

image of the lungs to assess changes consistent with pneumonia Frequency-1

Also known as: Picture of lungs

Subjects with Community-Acquired Pneumonia

urine specimen PROCEDURE

assay for the presence of Streptococcus pneumoniae Binax and UAD

Also known as: urine dipstick test

Subjects with Community-Acquired Pneumonia

Nasopharyngeal swab PROCEDURE

culture for Streptococcus pneumoniae Frequency-1

Also known as: swab from inside the nose and throat

Subjects with Community-Acquired Pneumonia

sputum PROCEDURE

culture for Streptococcus pneumoniae Frequency-1

Also known as: collection secretions produced during cough

Subjects with Community-Acquired Pneumonia

Eligibility Criteria

• Age: 50 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Adult subjects 50 years of age or older
• Subject must reside in the surveillance area
• Subjects who present to a study healthcare facility where the treating physician clinically suspects CAP

You may not qualify if:

• Any subject who is transferred to a study healthcare facility after already being hospitalized for 48 hours or more at any other in-patient facility (such as a community hospital).
• Hospital Acquired pneumonia (ie, develops signs and symptoms of pneumonia after being hospitalized for 48 hours or more).

Sponsors & Collaborators

• Pfizer: lead

Study Sites (1)

Pfizer Investigational Site

Chrzanów, 32-500, Poland

Location

Related Links

• To obtain contact information for a study center near you, click here.

MeSH Terms

Conditions

Community-Acquired Pneumonia

Interventions

Blood Specimen Collection; X-Rays; Urine Specimen Collection

Condition Hierarchy (Ancestors)

Community-Acquired Infections; Infections; Pneumonia; Respiratory Tract Infections; Respiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Specimen Handling; Clinical Laboratory Techniques; Diagnostic Techniques and Procedures; Diagnosis; Punctures; Surgical Procedures, Operative; Investigative Techniques; Electromagnetic Radiation; Electromagnetic Phenomena; Magnetic Phenomena; Physical Phenomena; Radiation; Radiation, Ionizing

Study Officials

• Pfizer CT.gov Call Center

  Pfizer

  STUDY DIRECTOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 26, 2009
• First Posted: June 29, 2009
• Study Start: December 1, 2009
• Primary Completion: January 1, 2012
• Study Completion: February 1, 2012
• Last Updated: April 13, 2012

Record last verified: 2012-04

Locations

PL (1)